Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
9,674
datasets available to search
ShareScore release 0.7.1
Dataset results
9,674 results for “COVID-19”
RESISTIRÉ Dataset: Narratives on inequalities caused by policy and societal responses to Covid-19 in Europe – third cycle
<p>This dataset contains 289 narratives, including keywords and specifically telling quotes. It is the third of three sets of narratives collected and analysed in RESISTIRÉ. These narrative interviews were conducted in national languages by the consortium partners and a network of national researchers covering the EU27 (except Malta), and Iceland, Serbia, and the UK in September-December 2022.<a href="#_ftn1">[1]</a> Narrative interviewing is a qualitative research method that involves inviting participants to tell their own stories and experiences in their own words. The technique is used to collect and share a person’s story which entails both a research methodology and a mechanism for storytelling i.e. both a way of telling a story, and a way of knowing<em>. </em>Narratives as a technique can make visible how multiple sources of inequalities intersect, as well as the situational and contextual nature of inequalities from a single person’s perspective.</p> <p> </p> <p><a href="#_ftnref1">[1]</a> For an analysis of the narratives, see Sandström, L., Callerstig, A-C., Strid, S., Lionello, L., & Rossetti, F. (2023). RESISTIRE D4.3 Summary report on qualitative indicators - cycle 3. Zenodo. <a href="https://doi.org/10.5281/zenodo.7708724">https://doi.org/10.5281/zenodo.7708724</a>.</p>
[Dataset] Tweets about COVID-19 Brazilian PCI
<p>Installed in April 2021, the COVID-19 Parliamentary Commission of Inquiry (PCI) aimed to investigate omissions and irregularities committed by the federal government during the COVID pandemic in Brazil, which resulted in the death of more than 660,000 Brazilians and placed it among the countries with the most deaths caused by COVID-19.</p> <p>This dataset has 3,397,933 tweets, splitted in days and weeks, extracted over a period of 26 weeks. It contains textual data from tweets, data about users (@ and description), and data about interactions between users. It can be used to improve textual cleaning techniques, toxic speech detection, clustering, and even Social Network Analysis and social graph studies. Data format is parquet.</p> <p>This dataset is part of a [paper](https://doi. org/10.1145/3539637.3556992)[1], published by its author, which aimed to do a social network analysis related to the CPI topic, to investigate evidence of political polarization. The source codes and jupyter notebooks are available on <a href="https://github.com/lucasraniere/twitter-cpi-case-study">GitHub</a>.</p> <p>[1] Uniting Politics and Pandemic: a Social Network Analysis on the COVID Parliamentary Commission of Inquiry in Brazil. WebMedia 2022. Lucas Raniére J. Santos, Leandro B. Marinho, Caludio E. C. Campelo.</p>
Characterization of the anti-spike IgG immune response to COVID-19 vaccines in people with a wide variety of immunodeficiencies
<p>Research on COVID-19 vaccination in immune-deficient/disordered people (IDP) has primarily focused on cancer and organ transplantation populations. In a prospective cohort of 195 IDP and 35 healthy volunteers, anti-spike IgG was detected in 88% of IDP post-dose 2, increasing to 93% by six months post-dose 3. Despite high seroconversion, median IgG levels for IDP never surpassed 1/3 that of healthy volunteers. IgG binding to Omicron BA.1 was lower than all other variants. Angiotensin-converting enzyme 2 pseudo-neutralization (% inhibition) was only modestly correlated with anti-spike IgG concentration. IgG levels were not significantly altered by participants' use of different mRNA-based vaccines, immunomodulating treatments, and prior SARS-CoV-2 infections. While our data show that three doses of COVID-19 vaccinations induce anti-spike IgG in most IDP, additional doses are needed to achieve the levels of protection in healthy volunteers. Due to the strikingly reduced IgG response to Omicron BA.1, the efficacy of additional vaccinations, including bivalent vaccines, should be studied in this population.</p>
Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older
ClinicalTrials.gov study NCT04762680. IPD Sharing: YES. Countries: 7. Publications: 2.
Predictors of Recovery and the App-Facilitated Tele-Rehabilitation (AFTER) Program for COVID-19 Survivors
ClinicalTrials.gov study NCT04663945. IPD Sharing: YES. Countries: 1. Publications: 2.
Sarilumab COVID-19
ClinicalTrials.gov study NCT04327388. IPD Sharing: YES. Countries: 11. Publications: 1.
Reducing Hopelessness Through Improved Physical Activity in Adults With Heart Disease: With COVID-19 Considerations
ClinicalTrials.gov study NCT03907891. IPD Sharing: YES. Countries: 1. Publications: 5.
A Single Heterologous Booster Vaccination Study of TAK-019 in Healthy Japanese Adults (COVID-19)
ClinicalTrials.gov study NCT05299359. IPD Sharing: YES. Countries: 1. Publications: 2.
Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19)
ClinicalTrials.gov study NCT04409509. IPD Sharing: YES. Countries: 1. Publications: 1.
Evaluation of Full Versus Fractional Doses of COVID-19 Vaccines Given as a Booster in Adults in Australia - Mongolia, Indonesia, Australia Coronavirus (MIACoV).
ClinicalTrials.gov study NCT05228730. IPD Sharing: YES. Countries: 1. Publications: 1.
COVID-19 and the Healthy Minds Program for Educators
ClinicalTrials.gov study NCT04426318. IPD Sharing: YES. Countries: 1. Publications: 5.
Sarilumab for Patients With Moderate COVID-19 Disease
ClinicalTrials.gov study NCT04359901. IPD Sharing: YES. Countries: 1. Publications: 6.
Efficacy of Oral Rinses for Inactivation of COVID-19 (MOR2)
ClinicalTrials.gov study NCT05178173. IPD Sharing: YES. Countries: 1. Publications: 12.
Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19
ClinicalTrials.gov study NCT04748783. IPD Sharing: YES. Countries: 1. Publications: 14.
Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19
ClinicalTrials.gov study NCT04545047. IPD Sharing: NO. Countries: 1. Publications: 1.
Pegylated Interferon Lambda Treatment for COVID-19
ClinicalTrials.gov study NCT04343976. IPD Sharing: YES. Countries: 1. Publications: 1.
COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists: A Stepped-Wedge Trial
ClinicalTrials.gov study NCT06547814. IPD Sharing: YES. Countries: 1. Publications: 5.
Exploring Changes in COVID-19 Vaccination Intentions by Prompting Altruistic Motives Using a Video Intervention
ClinicalTrials.gov study NCT04960228. IPD Sharing: NO. Countries: 1. Publications: 3.
Evaluation of Full Versus Fractional Dose of COVID-19 Vaccine Given as a Booster for the Prevention of COVID-19 in Adults in Mongolia.
ClinicalTrials.gov study NCT05265065. IPD Sharing: YES. Countries: 1. Publications: 3.
Study of Efficacy and Safety of MAS825 in Patients With COVID-19
ClinicalTrials.gov study NCT04382651. IPD Sharing: YES. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.